Your browser doesn't support javascript.
loading
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1.
Muik, Alexander; Quandt, Jasmin; Lui, Bonny Gaby; Bacher, Maren; Lutz, Sebastian; Grünenthal, Maika; Toker, Aras; Grosser, Jessica; Ozhelvaci, Orkun; Blokhina, Olga; Shpyro, Svetlana; Vogler, Isabel; Salisch, Nadine; Türeci, Özlem; Sahin, Ugur.
Afiliação
  • Muik A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Quandt J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Lui BG; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Bacher M; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Lutz S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Grünenthal M; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Toker A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Grosser J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Ozhelvaci O; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Blokhina O; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Shpyro S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Vogler I; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Salisch N; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Türeci Ö; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany; HI-TRON - Helmholtz Institute for Translational Oncology Mainz by DKFZ, Obere Zahlbacherstr. 63, 55131 Mainz, Germany.
  • Sahin U; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany; TRON gGmbH - Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Freiligrathstraße 12, 55131 Mainz, Germany. Electronic address: ugur.sahin@biontech.de.
Cell Rep ; 43(8): 114567, 2024 Aug 27.
Article em En | MEDLINE | ID: mdl-39097927
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure histories become increasingly complex through original and variant-adapted vaccines and infections with viral variants. Upon exposure to the highly altered Omicron spike glycoprotein, pre-immunized individuals predominantly mount recall responses of Wuhan-Hu-1 (wild-type)-imprinted memory B (BMEM) cells mostly targeting conserved non-neutralizing epitopes, leading to diminished Omicron neutralization. We investigated the impact of imprinting in individuals double/triple vaccinated with a wild-type-strain-based mRNA vaccine who, thereafter, had two consecutive exposures to Omicron BA.1 spike (breakthrough infection followed by BA.1-adapted vaccine). We found that depletion of conserved epitope-recognizing antibodies using a wild-type spike bait results in strongly diminished BA.1 neutralization. Furthermore, spike-specific BMEM cells recognizing conserved epitopes are much more prevalent than BA.1-specific BMEM cells. Our observations suggest that imprinted BMEM cell recall responses limit the induction of strain-specific responses even after two consecutive BA.1 spike exposures. Vaccine adaptation strategies need to consider that prior SARS-CoV-2 infections and vaccinations may cause persistent immune imprinting.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep / Cell reports Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep / Cell reports Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
...